PLASMA Trial: A Dose-Response Study of A-002 In Subjects With Stable Coronary Artery Disease

Cardiology, PC, Syracuse

Regional Clinical Research, Inc., Endwell

United Medical Associates, Binghamton

Lehigh Valley Hospital, Allentown

Clinical Research Associates of Tidewater, Norfolk

Augusta Cardiology Clinic, PC, Augusta

Broward General Medical Center, Fort Lauderdale

Florida Cardiovascular Institute, Tampa

Mobile Heart Specialists, Mobile

Louisville Cardiology Medical Group, Louisville

University of Michigan, Ann Arbor

Henry Ford Hospital, Detroit

Dnipropetrovs'k State Medical Academy, Dnepropetrovs'k

Winsconin Heart, SC, Madison

Black Hills Clinical Research Center, Rapid City

"Central Clinical Hospital Ukrzaliznysti", Khirkov

Institute of Therapy of AMS, Kharkiv

"Hospital of Radioprylad Plant", Zaporizhzhya

Central Arkansas Research, Hot Springs

Oklahoma Cardiovascular and Hypertension Center, Oklahoma City

Cardiopulmonary Research Science and Technology Institute, Dallas

Austin Heart, Austin

L'viv Regional State Clinical Treatment and Diagnostics, Lviv

Sonoran Health Specialists, Scottsdale

Charlotte Cardiovascuar Research, Port Charlotte

Hudson

Camp Hill

Strazhesko Institute of Cardiology AMS, Kyiv

Maine Research Associates, Auburn

Strazhesko Institute of Cardiology AMS, Kviv

Strazhesko Institute of Cardiology AMS, Kyiv

Kiev Central Hospital #1, Kyiv

City Clinical Hospital No 12, Kyiv

Scientific Centre of Endocrine Surgery, Kyiv

Institute of Gerontology AMS, Kyiv

Institute of Gerontology, Kyiv